Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
D.O.R.C. (Dutch Ophthalmic Research Center) is a leading global provider of innovative instruments and equipment for ophthalmic surgery, specifically focusing on vitreoretinal and cataract procedures. The company is best known for its flagship EVA NEXUS surgical platform, which utilizes advanced fluidics and high-speed vitrectomy technology to enhance surgical precision. Their extensive portfolio also includes a wide range of micro-surgical instruments and specialized surgical liquids and stains, such as VisionBlue and MembraneBlue-Dual, designed to improve visualization for surgeons. In April 2024, D.O.R.C. was acquired by Carl Zeiss Meditec, a move that integrates its high-end surgical solutions into one of the world's largest ophthalmology portfolios. The company continues to operate as a key innovation hub for surgical eye care from its headquarters in the Netherlands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dutch Ophthalmic Research Center International.